- Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres. Barry, A.L., Fuchs, P.C., Brown, S.D. J. Antimicrob. Chemother. (1998)